Norethindrone Acetate in the Medical Management of Adenomyosis
The role of norethindrone acetate (NA) in the management of adenomyosis was evaluated with a retrospective chart review of 28 premenopausal women between 27–49 years of age presenting with moderate to severe pelvic pain and bleeding. Bleeding and dysmenorrhea scores were analyzed using paired T-test...
שמור ב:
| Principais autores: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2012-10-01
|
| סדרה: | Pharmaceuticals |
| נושאים: | |
| גישה מקוונת: | http://www.mdpi.com/1424-8247/5/10/1120 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
